Accrued Liabilities, Current in USD of DA32 Life Science Tech Acquisition Corp. from Q3 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
DA32 Life Science Tech Acquisition Corp. quarterly Accrued Liabilities, Current history and change rate from Q3 2021 to Q1 2023.
  • DA32 Life Science Tech Acquisition Corp. Accrued Liabilities, Current for the quarter ending 31 Mar 2023 was $432K, a 91.5% increase year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

DA32 Life Science Tech Acquisition Corp. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $432K +$206K +91.5% 31 Mar 2023 10-Q 12 May 2023
Q4 2022 $420K +$276K +192% 31 Dec 2022 10-Q 12 May 2023
Q3 2022 $327K +$200K +158% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $261K 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $226K 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $144K 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $127K 30 Sep 2021 10-Q 15 Nov 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.